ShareHope Medicine Co., Ltd. (8403) Stock Statistics & Valuation Metrics
Total Valuation
ShareHope Medicine Co., Ltd. has a market cap or net worth of TWD 2.44B. The enterprise value is TWD 3.27B.
- Market Cap
- TWD 2.44B
- Enterprise Value
- TWD 3.27B
Share Statistics
ShareHope Medicine Co., Ltd. has 137,640,350 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 137,640,350
- Owned by Insiders
- ―
- Owned by Institutions
- 0.25%
Financial Efficiency
ShareHope Medicine Co., Ltd.’s return on equity (ROE) is 0.04 and return on invested capital (ROIC) is 1.06%.
- Return on Equity (ROE)
- 0.04
- Return on Assets (ROA)
- 0.02
- Return on Invested Capital (ROIC)
- 1.06%
- Return on Capital Employed (ROCE)
- 0.02
- Revenue Per Employee
- 36.93M
- Profits Per Employee
- 1.20M
- Employee Count
- 118
- Asset Turnover
- 0.66
- Inventory Turnover
- 12.97
Valuation Ratios
The current PE Ratio of ShareHope Medicine Co., Ltd. is 15.76. ShareHope Medicine Co., Ltd.’s PEG ratio is -3.28.
- PE Ratio
- 15.76
- PS Ratio
- 0.57
- PB Ratio
- 0.81
- Price to FCF
- 7.78
- Price to Operating Cash Flow
- 6.49
- PEG Ratio
- -3.28
Income Statement
In the last 12 months, ShareHope Medicine Co., Ltd. had revenue of 4.36B and earned 141.73M in profits. Earnings per share was 1.03.
- Revenue
- 4.36B
- Gross Profit
- 573.78M
- Operating Income
- 80.81M
- Pretax Income
- 150.15M
- Net Income
- 141.73M
- EBITDA
- 349.13M
- Earnings Per Share (EPS)
- 1.03
Cash Flow
In the last 12 months, operating cash flow was 412.08M and capital expenditures -80.45M, giving a free cash flow of 331.62M billion.
- Operating Cash Flow
- 412.08M
- Free Cash Flow
- 331.62M
- Free Cash Flow per Share
- 2.32
Dividends & Yields
ShareHope Medicine Co., Ltd. pays an annual dividend of ―, resulting in a dividend yield of 3.38%
- Dividend Per Share
- ―
- Dividend Yield
- 3.38%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 12.95%
- Earnings Yield
- 6.31%
Stock Price Statistics
- Beta
- 0.25
- 52-Week Price Change
- -26.20%
- 50-Day Moving Average
- 18.89
- 200-Day Moving Average
- 19.94
- Relative Strength Index (RSI)
- 17.94
- Average Volume (3m)
- 90.48K
Important Dates
ShareHope Medicine Co., Ltd. upcoming earnings date is Mar 12, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Nov 06, 2026
- Next Earnings Date
- Mar 12, 2027
- Ex-Dividend Date
- ―
Financial Position
ShareHope Medicine Co., Ltd. as a current ratio of 2.00, with Debt / Equity ratio of 52.23%
- Current Ratio
- 2.00
- Quick Ratio
- 1.82
- Debt to Market Cap
- 0.52
- Net Debt to EBITDA
- 1.32
- Interest Coverage Ratio
- 1.69
Taxes
In the past 12 months, ShareHope Medicine Co., Ltd. has paid 38.25M in taxes.
- Income Tax
- 38.25M
- Effective Tax Rate
- 0.25
Enterprise Valuation
ShareHope Medicine Co., Ltd. EV to EBITDA ratio is 7.58, with an EV/FCF ratio of 8.74.
- EV to Sales
- 0.64
- EV to EBITDA
- 7.58
- EV to Free Cash Flow
- 8.74
- EV to Operating Cash Flow
- 7.03
Balance Sheet
ShareHope Medicine Co., Ltd. has TWD 1.54B in cash and marketable securities with TWD 1.77B in debt, giving a net cash position of -TWD 237.72M billion.
- Cash & Marketable Securities
- TWD 1.54B
- Total Debt
- TWD 1.77B
- Net Cash
- -TWD 237.72M
- Net Cash Per Share
- -TWD 1.73
- Tangible Book Value Per Share
- TWD 23.75
Margins
Gross margin is 15.34%, with operating margin of 4.36%, and net profit margin of 3.72%.
- Gross Margin
- 15.34%
- Operating Margin
- 4.36%
- Pretax Margin
- 4.42%
- Net Profit Margin
- 3.72%
- EBITDA Margin
- 8.51%
- EBIT Margin
- 4.25%
Analyst Forecast
The average price target for ShareHope Medicine Co., Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 6.25%
- EPS Growth Forecast
- 14.37%
